Literature DB >> 10654025

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect.

R K Burt1, J Guitart, A Traynor, C Link, S Rosen, T Pandolfino, T M Kuzel.   

Abstract

Allogeneic hematopoietic stem cell transplantation should be considered as a therapeutic option for patients with generalized erythoderma or tumor stage MF. Indeed, the only curative option for MF may be an allogeneic transplant. Bone Marrow Transplantation (2000) 25, 111-113.

Entities:  

Mesh：

Year:  2000        PMID： 10654025     DOI： 10.1038/sj.bmt.1702099

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  9 in total

1.  Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.

Authors:  Esperanza B Papadopoulos; Miguel-Angel Perales; Jenna D Goldberg; Joanne F Chou; Steven Horwitz; Julie Teruya-Feldstein; Juliet N Barker; Farid Boulad; Hugo Castro-Malaspina; Sergio Giralt; Ann A Jakubowski; Guenther Koehne; Marcel R M van den Brink; James W Young; Zhigang Zhang
Journal:  Leuk Lymphoma       Date:  2012-01-31

2.  Diverse cutaneous manifestations associated with a single disease.

Authors:  Jennifer Clay Cather; Estil A Vance; M Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

Review 3.  Cutaneous T-cell lymphomas: a review of new discoveries and treatments.

Authors:  Tara Bloom; Timothy M Kuzel; Christiane Querfeld; Joan Guitart; Steven T Rosen
Journal:  Curr Treat Options Oncol       Date:  2012-03

4.  Successful cord blood transplantation for mycosis fungoides.

Authors:  Takuya Fukushima; Kensuke Horio; Emi Matsuo; Daisuke Imanishi; Reishi Yamasaki; Hideki Tsushima; Yoshitaka Imaizumi; Koichi Ohshima; Tomoko Hata; Shinichiro Yoshida; Yasushi Miyazaki; Masao Tomonaga
Journal:  Int J Hematol       Date:  2008-11-08       Impact factor: 2.490

5.  Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation.

Authors:  M López-Duarte; A Insunza; E Conde; A Iriondo; F Mazorra; A Zubizarreta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-27       Impact factor: 3.267

Review 6.  Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Authors:  Ellen J Kim; Stephen Hess; Stephen K Richardson; Sara Newton; Louise C Showe; Bernice M Benoit; Ravi Ubriani; Carmela C Vittorio; Jacqueline M Junkins-Hopkins; Maria Wysocka; Alain H Rook
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 7.  Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.

Authors:  Max Schlaak; Juliane Pickenhain; Sebastian Theurich; Nicole Skoetz; Michael von Bergwelt-Baildon; Peter Kurschat
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

8.  Management Strategies for Mycosis Fungoides in India.

Authors:  Tanumay Raychaudhury
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494

9.  Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis.

Authors:  Florentia Dimitriou; Urs Schanz; Gayathri Nair; Susanne Kimeswenger; Marie-Charlotte Brüggen; Wolfram Hoetzenecker; Lars E French; Reinhard Dummer; Antonio Cozzio; Emmanuella Guenova
Journal:  Front Med (Lausanne)       Date:  2020-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.